1.46
-0.075(-4.90%)
Currency In USD
| Previous Close | 1.53 |
| Open | 1.54 |
| Day High | 1.54 |
| Day Low | 1.44 |
| 52-Week High | 3.38 |
| 52-Week Low | 0.82 |
| Volume | 440,824 |
| Average Volume | 4.25M |
| Market Cap | 50.55M |
| PE | -1.84 |
| EPS | -0.79 |
| Moving Average 50 Days | 1.78 |
| Moving Average 200 Days | 1.19 |
| Change | -0.08 |
If you invested $1000 in Microbot Medical Inc. (MBOT) 10 years ago, it would be worth $0.72 as of March 13, 2025 at a share price of $1.455. Whereas If you bought $1000 worth of Microbot Medical Inc. (MBOT) shares 5 years ago, it would be worth $291.58 as of March 13, 2025 at a share price of $1.455.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System
GlobeNewswire Inc.
Mar 04, 2025 1:30 PM GMT
Mr. Paul Mullen Most Recently Served as the Director of Sales at Inari Medical which was Acquired by Stryker Corporation Earlier This Year This Appointment Represents the Company’s First Commercial Hire as it Ramps Up Commercial Readiness in Anticipa
Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting
GlobeNewswire Inc.
Feb 25, 2025 1:30 PM GMT
Research Collaboration demonstrates the feasibility of using the LIBERTY® Endovascular Robotic System between separate and remote facilities in a coronary simulation modelBRAINTREE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (N
Microbot Medical Closes $13 Million Registered Direct Offering
GlobeNewswire Inc.
Feb 11, 2025 11:15 PM GMT
BRAINTREE, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 6,103,2